Yanagitani N - Search Results

1

[A case of multidrug-resistant non-small cell lung cancer responding to TS-1].

Imai H, Sunaga N, Kaira K, Ishihara S, Aoki H, Iijima H, Yanagitani N, Iwasaki Y, Tomizawa Y, Saito R, Mori M. Imai H, et al. Among authors: yanagitani n. Gan To Kagaku Ryoho. 2007 Feb;34(2):221-4. Gan To Kagaku Ryoho. 2007. PMID: 17301531 Japanese.

2

A Retrospective, Multicenter, Observational Study to Evaluate Clinical Outcomes of Lorlatinib After Alectinib in Patients With ALK-Positive NSCLC in Japan.

Goto Y, Kenmotsu H, Tamiya M, Murakami S, Kurata T, Yanagitani N, Taniguchi H, Kuyama S, Shimizu J, Yokoyama T, Shimada N, Maeda T, Tamiya A, Uchiyama A, Imaizumi K, Takahama T, Kato T, Hayashi H, Shiraiwa N, Toyoizumi S, Kikkawa H, Thomaidou D, Nishio M. Goto Y, et al. Among authors: yanagitani n. JTO Clin Res Rep. 2023 Mar 24;4(5):100508. doi: 10.1016/j.jtocrr.2023.100508. eCollection 2023 May. JTO Clin Res Rep. 2023. PMID: 37250506 Free PMC article.

3

Clinical characteristics of patients with KRAS mutation detected by liquid biopsy.

Amino Y, Low SK, Ninomiya H, Kiritani A, Miyadera K, Kakuto S, Akita T, Tsugitomi R, Ariyasu R, Uchibori K, Kitazono S, Yanagitani N, Nishio M. Amino Y, et al. Among authors: yanagitani n. Thorac Cancer. 2023 Nov;14(33):3317-3322. doi: 10.1111/1759-7714.15123. Epub 2023 Sep 26. Thorac Cancer. 2023. PMID: 37751775 Free PMC article.

4

Effectiveness and Safety of Atezolizumab Monotherapy in Previously Treated Japanese Patients With Unresectable Advanced or Recurrent NSCLC: A Multicenter, Prospective, Observational Study (J-TAIL).

Miura S, Nishio M, Akamatsu H, Goto Y, Hayashi H, Gemma A, Yoshino I, Misumi T, Hata A, Hataji O, Fujita K, Seike M, Yanagitani N, Nishino K, Hara S, Saito R, Mori M, Tsuda T, Iwasawa S, Nakagawa S, Mitsudomi T. Miura S, et al. Among authors: yanagitani n. JTO Clin Res Rep. 2023 Feb 24;4(3):100484. doi: 10.1016/j.jtocrr.2023.100484. eCollection 2023 Mar. JTO Clin Res Rep. 2023. PMID: 37034464 Free PMC article.

5

Real-World Outcome Analysis of Patients With Stage IV NSCLC Treated With Tyrosine Kinase and Immune Checkpoint Inhibitors.

Ariyasu R, Kakuto S, Miyadera K, Akita T, Kiritani A, Tsugitomi R, Amino Y, Uchibori K, Kitazono S, Yanagitani N, Nishio M. Ariyasu R, et al. Among authors: yanagitani n. JTO Clin Res Rep. 2023 May 4;4(6):100524. doi: 10.1016/j.jtocrr.2023.100524. eCollection 2023 Jun. JTO Clin Res Rep. 2023. PMID: 37426307 Free PMC article.

6

Localization of a human lung adenocarcinoma susceptibility locus, possibly syntenic to the mouse Pas1 locus, in the vicinity of the D12S1034 locus on chromosome 12p11.2-p12.1.

Yanagitani N, Kohno T, Sunaga N, Kunitoh H, Tamura T, Tsuchiya S, Saito R, Yokota J. Yanagitani N, et al. Carcinogenesis. 2002 Jul;23(7):1177-83. doi: 10.1093/carcin/23.7.1177. Carcinogenesis. 2002. PMID: 12117776

7

Contribution of the NQO1 and GSTT1 polymorphisms to lung adenocarcinoma susceptibility.

Sunaga N, Kohno T, Yanagitani N, Sugimura H, Kunitoh H, Tamura T, Takei Y, Tsuchiya S, Saito R, Yokota J. Sunaga N, et al. Among authors: yanagitani n. Cancer Epidemiol Biomarkers Prev. 2002 Aug;11(8):730-8. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12163326

8

Papillary adenocarcinoma of the lung is a more advanced adenocarcinoma than bronchioloalveolar carcinoma that is composed of two distinct histological subtypes.

Jian Z, Tomizawa Y, Yanagitani N, Iijima H, Sano T, Nakajima T. Jian Z, et al. Among authors: yanagitani n. Pathol Int. 2005 Oct;55(10):619-25. doi: 10.1111/j.1440-1827.2005.01879.x. Pathol Int. 2005. PMID: 16185291

9

A case of primary peritoneal serous papillary carcinoma initially presented by massive bilateral pleural effusions.

Kaira K, Takise A, Endou K, Yanagitani N, Sunaga N, Mori M. Kaira K, et al. Among authors: yanagitani n. Eur J Gynaecol Oncol. 2006;27(2):197-9. Eur J Gynaecol Oncol. 2006. PMID: 16620072

10

Small cell carcinoma of the larynx in a long-term survivor of small-cell lung cancer.

Kaira K, Ishizuka T, Sohara N, Yanagitani N, Sunaga N, Tsuchiya T, Mori M. Kaira K, et al. Among authors: yanagitani n. J Clin Oncol. 2006 Jun 20;24(18):2961-3. doi: 10.1200/JCO.2005.04.8736. J Clin Oncol. 2006. PMID: 16782935 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

159 results

Search Page

Filters